Skip to main content

Dr. Gaggar is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gaggar's full profile

Already have an account?

Education & Training

  • University of California (San Francisco) School of Medicine
    University of California (San Francisco) School of MedicineFellowship, Infectious Disease, 2008 - 2011
  • University of California (San Francisco) School of Medicine
    University of California (San Francisco) School of MedicineResidency, Internal Medicine, 2006 - 2010
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19  
    Robert L Gottlieb, Gerard J Criner, Onyema Ogbuagu, Kathleen M Mullane, Anuj Gaggar, Diana M Brainard, Gregory Huhn, JAMA

Authored Content

  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Join now to see all

Press Mentions

  • Trial Finds Drug Safe and Effective in Treating Hep-C During Pregnancy
    Trial Finds Drug Safe and Effective in Treating Hep-C During PregnancyJuly 28th, 2020